Successful Treatment of Bilateral Diffuse Uveal Melanocytic Proliferation With Plasmapheresis

2017 ◽  
Vol 1 (6) ◽  
pp. 420-423
Author(s):  
Matthew S. J. Katz ◽  
Henry Alexander Leder ◽  
Tahsin Choudhury

Introduction: Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a rare paraneoplastic disorder that bears grave ocular prognosis. No consensus exists regarding treatment regimen and very little has been achieved in the way of successful treatment. We present here a case of BDUMP associated with metastatic non–small cell lung carcinoma treated successfully with plasmapheresis. Methods: This is a nonmasked, retrospective interventional case study conducted at a tertiary care center, characterizing bilateral disease in 1 patient, and describing response to plasmapheresis. Outcome measures were resolution of optical coherence tomography (OCT) findings, as well as visual response. Results: Resolution of bilateral exudative retinal detachments was documented with both ophthalmoscopic photography and OCT and accompanied by concurrent improvement in visual function. Conclusion: Bilateral diffuse uveal melanocytic proliferation has been treated with plasmapheresis in only 3 previously reported cases. This case demonstrates and reinforces the great promise in the treatment of this rare and devastating condition.

2016 ◽  
Vol 9 (1) ◽  
pp. 171-176 ◽  
Author(s):  
Corey A. Carter ◽  
Bryan T. Oronsky ◽  
Scott Z. Caroen ◽  
Jan J. Scicinski ◽  
Aiste Degesys ◽  
...  

RRx-001 is a pan-active, systemically nontoxic epigenetic inhibitor under investigation in advanced non-small cell lung cancer, small-cell lung cancer and high-grade neuroendocrine tumors in a Phase II clinical trial entitled TRIPLE THREAT (NCT02489903), which reexposes patients to previously effective but refractory platinum doublets after treatment with RRx-001. The purpose of this case study is first to report a partial response to carboplatin and etoposide in a patient with small-cell lung cancer pretreated with RRx-001, indicating episensitization or resensitization by epigenetic mechanisms, and second to discuss the literature related to small-cell lung cancer and episensitization.


2019 ◽  
Vol 10 (5) ◽  
pp. 1285-1288 ◽  
Author(s):  
Tomoyuki Naito ◽  
Shigeki Umemura ◽  
Hiroshi Nakamura ◽  
Yoshitaka Zenke ◽  
Hibiki Udagawa ◽  
...  

2021 ◽  
Vol 14 ◽  
pp. 2632010X2110517
Author(s):  
Pamela Hernandez-Arriaga ◽  
Mauricio Gonzalez-Urquijo ◽  
Daniel Fernando López Altamirano ◽  
Bryan Vaca-Cartagena ◽  
Andres Vergil-Vargas ◽  
...  

Lambert-Eaton syndrome is a rare paraneoplastic disorder of the neuromuscular junction, characterized by impaired release of acetylcholine, which causes proximal muscle weakness, depressed tendon reflexes, and autonomic changes. Most cases of Lambert-Eaton syndrome present in small-cell lung carcinoma, and only a few cases have been reported in other lung subtypes. Herein, we report a case of 69 years old male patient with Lambert-Eaton syndrome as a rare association with a pulmonary large-cell neuroendocrine carcinoma, which presented 5 months before neoplasm diagnosis. A lobectomy was auspiciously performed. A review of the literature is also presented.


Sign in / Sign up

Export Citation Format

Share Document